Pharma Pricing & Market Access Keynotes

 

  • Carla Deakin at World Pharma Pricing and Market Access 2018
    Carla Deakin
    Associate Director, Office for Market Access
    NICE
    Andrew Dillon at World Pharma Pricing and Market Access 2018
    Andrew Dillon
    Chief Executive
    National Institute for Health and Care Excellence
    Barbara Jaszewski at World Pharma Pricing and Market Access 2018
    Barbara Jaszewski
    VP, Global Pricing & Market Access
    H. Lundbeck A/S
  • Sebastien Le Roux at World Pharma Pricing and Market Access 2018
    Sebastien Le Roux
    VP, Global Market Access & Healthcare Solutions
    Glaxo Smith Kline
    Farzana Malik at World Pharma Pricing and Market Access 2018
    Farzana Malik
    Vice President Market Access
    Vicarius Pharma
    Thomas Mueller at World Pharma Pricing and Market Access 2018
    Thomas Mueller
    Head of Pharmaceuticals
    G-BA
  • Jeff Myers at World Pharma Pricing and Market Access 2018
    Jeff Myers
    CEO
    Medicaid Health Plans of America
    Alexander Natz at World Pharma Pricing and Market Access 2018
    Alexander Natz
    Secretary General
    EUCOPE
    Tanya Potashnik at World Pharma Pricing and Market Access 2018
    Tanya Potashnik
    Director Policy & Economic Analysis, Patented Medicine Prices Review Board
    Goverment Of Canada
  • Marco Rauland at World Pharma Pricing and Market Access 2018
    Marco Rauland
    Global Head Pricing & Payer Excellence
    Merck Group
    Anne Toni Rodgers at World Pharma Pricing and Market Access 2018
    Anne Toni Rodgers
    Global Head Operations Payer And Real World Evidence
    AstraZeneca
    Gundula Schneidewind at World Pharma Pricing and Market Access 2018
    Gundula Schneidewind
    Vice President
    Takeda
  • Rob Scott at World Pharma Pricing and Market Access 2018
    Rob Scott
    Chief Medical Officer, VP, Head of Development
    AbbVie
    Erik Smets at World Pharma Pricing and Market Access 2018
    Erik Smets
    Vice President, Head of Patient Experience and Value
    U.C.B. Pharma
    Keiko Tone at World Pharma Pricing and Market Access 2018
    Keiko Tone
    VP Market Access
    Shionogi Limited
  • John Bardi at World Pharma Pricing and Market Access 2018
    John Bardi
    Vice President Public Affairs and Digital Medicine Business Development
    Otsuka America Pharmaceuticals Inc.
    Shameer Khader at World Pharma Pricing and Market Access 2018
    Shameer Khader
    Director of Bioinformatics, Data Science & Precision Medicine
    Philips
    Diane Munch at World Pharma Pricing and Market Access 2018
    Diane Munch
    Senior Director of Global Pricing
    Pfizer
  • Lara Pippo at World Pharma Pricing and Market Access 2018
    Lara Pippo
    Head of Market Access
    C.S.L. Behring Spa
    Kasia Hein Peters at World Pharma Pricing and Market Access 2018
    Kasia Hein Peters
    Vice President and Head of Marketing Dengue Vaccine
    Sanofi Pasteur
    Jayne Spink at World Pharma Pricing and Market Access 2018
    Jayne Spink
    Chief Executive Officer
    Genetic Alliance U.K.

 

All Early Confirmed 2018 Speakers

Nicola Allen, Senior Consultant, Precision for Value

Nicola Allen at World Pharma Pricing and Market Access 2018

John Alter, Vice President Pricing and Market Access, Pfizer

John Alter at World Pharma Pricing and Market Access 2018

Adel Alzahrani, Senior Pharmacist, Saudi Food & Drug Authority

Adel Alzahrani at World Pharma Pricing and Market Access 2018

Nadeem Ashraf, Digital Lead for Medical Affairs & PRA (Pricing, Reimbursement & Access) for Europe & Canada, Lilly

Cheryl Ball, VP, Evidera

Cheryl Ball at World Pharma Pricing and Market Access 2018

John Bardi, Vice President Public Affairs and Digital Medicine Business Development, Otsuka America Pharmaceuticals Inc.

Katja Berg, Vice President of Operations and Payers Intelligence, Sanofi

Katja Berg at World Pharma Pricing and Market Access 2018

Luc Boileau, Président-directeur general, Inesss

Luc Boileau at World Pharma Pricing and Market Access 2018

Hassan Bruneo, Associate Director, Alnylam

Hassan Bruneo at World Pharma Pricing and Market Access 2018

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics at World Pharma Pricing and Market Access 2018

José Luis Sánchez Chorro, Head of Market Access, Shire Pharmaceuticals

Wim Colle, President Pulmonary Hypertension Belgium, Flemish Patients Platform vzw

Wim Colle at World Pharma Pricing and Market Access 2018

Emily Crossley, Cofounder, Duchenne U.K.

Emily Crossley at World Pharma Pricing and Market Access 2018

Omar Dabbous, Head of Quantitative Science Payer Evidence Group, GlaxoSmith Kline

Omar Dabbous at World Pharma Pricing and Market Access 2018

Carla Deakin, Associate Director, Office for Market Access, NICE

Jose Diaz, Group Director – JKT Cluster & Intercon Lead - WWHEOR Markets, Bristol Myers Squibb

Jose Diaz at World Pharma Pricing and Market Access 2018

Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence

Andrew Dillon at World Pharma Pricing and Market Access 2018

Mark Duman, Non Executive Director, Patient Information Forum

Will Dunlop, Head of Market Access, Mundipharma International Limited

Will Dunlop at World Pharma Pricing and Market Access 2018

Jenny Ebert, Account Director, Genzyme Sanofi Corp

Jenny Ebert at World Pharma Pricing and Market Access 2018

Kiri Fatania-Morley, Patient Advocate, Patient/Parent Advocate

Kiri Fatania-Morley at World Pharma Pricing and Market Access 2018

Hans Peter Frank, Global Head of Integrated Solutions, Vifor Fresenius Medical Care Renal Pharma Ltd

Hans Peter Frank at World Pharma Pricing and Market Access 2018

Ben Gannon, Senior Director of Global Government Affairs and Policy, Vertex Pharmaceuticals

Ben Gannon at World Pharma Pricing and Market Access 2018

Fabrizio Gianfrate, Professor of Health Economics, Mkt Access Advisor, Universities of Rome and Ferrara

Josie Godfrey, Independent, Duchenne U.K.

Josie Godfrey at World Pharma Pricing and Market Access 2018

Wim Goettsch, Director of EUnetHTA JA3, Zorginstituut

Alicia Granados, Head of Global Health Technology Assessment (HTA) OPI GMAx, Sanofi

Alicia Granados at World Pharma Pricing and Market Access 2018

Adrian Griffin, VP, HTA and Reimbursement Policy, Johnson & Johnson

Adrian Griffin at World Pharma Pricing and Market Access 2018

Alexander Grosvenor, Senior Principal of Global Pricing and Market Access, Precision for Value

Alexander Grosvenor at World Pharma Pricing and Market Access 2018

Mohamed Hamada, Country Portfolio Lead, Women’s Health – Egypt & Sudan, Pfizer

Emma Harvey, Senior Medical Director, Alexion Pharmaceuticals

Ansgar Hebborn, Head of Global H.T.A. and Payment Policy, F Hoffman La Roche Ag

Ansgar Hebborn at World Pharma Pricing and Market Access 2018

Tony Hebden, Vice President of Health Economics and Outcomes Research, AbbVie

Tony Hebden at World Pharma Pricing and Market Access 2018

Kasia Hein Peters, Vice President and Head of Marketing Dengue Vaccine, Sanofi Pasteur

Kasia Hein Peters at World Pharma Pricing and Market Access 2018

Alan Hochberg, Scientific Enablement Leader, F. Hoffmann-La Roche Ltd

Karen Hockey, Director, Global Market Access & Government Affairs, Norgine Ltd

Patrick Hopkinson, Executive Director, WWHEOR Markets, Bristol-Myers Squibb

Nigel Hughes, Scientific Director, RMEDS (Real World Evidence, Medical Affairs, Established Products, Statistics) Quantitative Sciences, Janssen Research & Development

Dawn Torrence Ireland, President and Founder, C.H.E.R.U.B.S.

Dawn Torrence Ireland at World Pharma Pricing and Market Access 2018

Rachel Jao, Vice President, Accounts & Analytics,, Context Matters Inc

Rachel Jao at World Pharma Pricing and Market Access 2018

Barbara Jaszewski, VP, Global Pricing & Market Access, H. Lundbeck A/S

Barbara Jaszewski at World Pharma Pricing and Market Access 2018

Navin Joshi, Head of Pricing & Access Capabilities EMAP, GlaxoSmithKline

Navin Joshi at World Pharma Pricing and Market Access 2018

Marcela Junqueira, Head of Value Demonstration and Access, Shire Farmacêutica Brasil Ltda

Marcela Junqueira at World Pharma Pricing and Market Access 2018

Sachin Kamal-Bahl, Vice President & Head, Global Health & Value Innovation Center, Pfizer

Sachin Kamal-Bahl at World Pharma Pricing and Market Access 2018

Marie Kane, Chief Operating Officer, NorthWest EHealth

Marie Kane at World Pharma Pricing and Market Access 2018

James Kavanagh, HEOR and Strategic Pricing Manager, AbbVie

James Kavanagh at World Pharma Pricing and Market Access 2018

Abdulkadir Keskinaslan, Head Medical Education Strategy LACan, Novartis Ag

Shameer Khader, Director of Bioinformatics, Data Science & Precision Medicine, Philips

Shameer Khader at World Pharma Pricing and Market Access 2018

Diane Kleinermans, Advisor to the Ministry of Health and Social Affairs Belgium, Belgian Federal Government

Margarita Landeira, Associate Director, EMEA Health Economics & Outcomes Research, Astellas Pharma

Margarita Landeira at World Pharma Pricing and Market Access 2018

Bruce Lavin, Vice President and Head of Medical Neurology, UCB

Sebastien Le Roux, VP, Global Market Access & Healthcare Solutions, Glaxo Smith Kline

Sally Lee, Director of Pharmacodepidemiology EMEA / APAC, Celgene

Sally Lee at World Pharma Pricing and Market Access 2018

Giovanny Leon, Pricing and Market Access Director for Latin America and Canada, Novartis Ag

Giovanny Leon at World Pharma Pricing and Market Access 2018

Friedhelm Leverkus, Director Health Technology Assessment and Outcomes Research, Pfizer

Friedhelm Leverkus at World Pharma Pricing and Market Access 2018

Julie Locklear, Vice President and Head of Health Economics and Outcomes Research, EMD Serono

Julie Locklear at World Pharma Pricing and Market Access 2018

Ben locwin, Ex-Executive Director Roche President, Healthcare Science Advisors, Roche & Genentech

Ben locwin at World Pharma Pricing and Market Access 2018

Fulvio Luccini, Patient Access head, Novartis italy

Fulvio Luccini at World Pharma Pricing and Market Access 2018

Mark MacGregor, Associate Medical Director and Clinical Advisor, Scottish Medicines Consortium, NHS National Services Scotland

Mark MacGregor at World Pharma Pricing and Market Access 2018

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at World Pharma Pricing and Market Access 2018

Joerg Mahlich, Director Health Economics, Janssen Pharmaceutical K.K.

Joerg Mahlich at World Pharma Pricing and Market Access 2018

Farzana Malik, Vice President Market Access, Vicarius Pharma

Farzana Malik at World Pharma Pricing and Market Access 2018

Andrea Mantovani, Director of Country Market Access, Sanofi Pharma and Vaccines

Andrea Mantovani at World Pharma Pricing and Market Access 2018

Marco Marchetti, Director of the National Center for Health Technology Assessment, Istituto Superiore di Sanita

Anne Marciniak, Affiliate, Brunel University

Anne Marciniak at World Pharma Pricing and Market Access 2018

Robert Meadowcroft, CEO, The Muscular Dystrophy U.K.

Patrick Mollon, Director GHEORE, Shire

Patrick Mollon at World Pharma Pricing and Market Access 2018

Thomas Mueller, Head of Pharmaceuticals, G-BA

Thomas Mueller at World Pharma Pricing and Market Access 2018

Neil Mulcock, Vice President Government Affairs and Policy, Gilead Sciences

Neil Mulcock at World Pharma Pricing and Market Access 2018

Diane Munch, Senior Director of Global Pricing, Pfizer

Diane Munch at World Pharma Pricing and Market Access 2018

Jeff Myers, CEO, Medicaid Health Plans of America

Jeff Myers at World Pharma Pricing and Market Access 2018

Siva Narayanan, VP and Global Head, Market Access, PTC

Alexander Natz, Secretary General, EUCOPE

Nneka Onwudiwe PharmD PhD MBA, PRO/PE Regulatory Reviewer, US Government

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski at World Pharma Pricing and Market Access 2018

Detlev Parow, Head of Department Care and Management Development, D.A.K. Gesundheit Zentrale

Britta Paschen, VP, Head of Global Evidence and Value Development, Merck KGaA

Britta Paschen at World Pharma Pricing and Market Access 2018

Mauro Patroncini, Pipeline Product Strategy Leader, Roche

Mauro Patroncini at World Pharma Pricing and Market Access 2018

Dan Pettitt, Global Head of Immunology Market Access, Johnson & Johnson

Dan Pettitt at World Pharma Pricing and Market Access 2018

Ed Pezalla, Former Vice President, National Medical Director for Pharmaceutical Policy and Strategy, Aetna

Ed Pezalla at World Pharma Pricing and Market Access 2018

Lara Pippo, Head of Market Access, C.S.L. Behring Spa

Lara Pippo at World Pharma Pricing and Market Access 2018

Klaas Postema, Senior Director Market Access & Pricing Generics Europe, Teva

Klaas Postema at World Pharma Pricing and Market Access 2018

Tanya Potashnik, Director Policy & Economic Analysis, Patented Medicine Prices Review Board, Goverment Of Canada

Diann Potestio, Senior Director, Market Access, West, Genzyme

Diann Potestio at World Pharma Pricing and Market Access 2018

John Procter, Head of Market Access Europe, QuintilesIMS

John Procter at World Pharma Pricing and Market Access 2018

Malcolm Qualie, Pharmacy Lead for Specialised Services, NHS England

Malcolm Qualie at World Pharma Pricing and Market Access 2018

Marco Rauland, Global Head Pricing & Payer Excellence, Merck Group

Marco Rauland at World Pharma Pricing and Market Access 2018

Gella Richards, Teaching Fellow, Queen Mary University of London

Gella Richards at World Pharma Pricing and Market Access 2018

Anne Toni Rodgers, Global Head Operations Payer And Real World Evidence, AstraZeneca

Anne Toni Rodgers at World Pharma Pricing and Market Access 2018

Giuseppe Rosano, Member of the Cardiovascular Working Party, European Medicines Agency

Giuseppe Rosano at World Pharma Pricing and Market Access 2018

Katja Rudell, Patient Services Manager, Shire Pharmaceuticals

Mete Saylan, MACS Director, Bayer plc

Mete Saylan at World Pharma Pricing and Market Access 2018

Fabian Schmidt, Head of Market Access and External Affairs, Orphan Europe

Fabian Schmidt at World Pharma Pricing and Market Access 2018

Gundula Schneidewind, Vice President, Takeda

Michael Schroter, Head of Personalised Reimbursment Models, Global Pricing and Market Access, Roche

Michael Schroter at World Pharma Pricing and Market Access 2018

Donato Scolozzi, Member of Spending Review Working Group, Ministry of Health Italy

Donato Scolozzi at World Pharma Pricing and Market Access 2018

Rob Scott, Chief Medical Officer, VP, Head of Development, AbbVie

Simon Shohet, Senior Director, Global Market Access and Pricing, Ipsen

Gerard Slevin, National hospitals manager, Clonmel Healthcare Ltd

Gerard Slevin at World Pharma Pricing and Market Access 2018

Erik Smets, Vice President, Head of Patient Experience and Value, U.C.B. Pharma

Erik Smets at World Pharma Pricing and Market Access 2018

Peter Speyer, Global Head of Real World Evidence Solutions, Novartis

Peter Speyer at World Pharma Pricing and Market Access 2018

Jayne Spink, Chief Executive Officer, Genetic Alliance U.K.

Jayne Spink at World Pharma Pricing and Market Access 2018

Richard Stephens, Chair of Consumer Liaison Group, National Cancer Research Institute

Bertrand Tardivel, Head of Global Pricing, Takeda Pharmaceuticals International

Bertrand Tardivel at World Pharma Pricing and Market Access 2018

Sam Taylor, Global Pricing Director, Pfizer Ltd

Sam Taylor at World Pharma Pricing and Market Access 2018

Thomas Temme, Head of Value Demonstration & Access & Public Affairs, Germany, Austria and Switzerland, Shire

Thomas Temme at World Pharma Pricing and Market Access 2018

Keiko Tone, VP Market Access, Shionogi Limited

Keiko Tone at World Pharma Pricing and Market Access 2018

Dimitar Tonev, Medical Director, Promethera Biosciences

Dimitar Tonev at World Pharma Pricing and Market Access 2018

Dimitrios Tsourougiannis, Associate Director, EMEA Health Economics & Outcomes Research, Astellas Pharma Europe Ltd

Dimitrios Tsourougiannis at World Pharma Pricing and Market Access 2018

Jane Turner, Senior Principal, Real World Evidence, ICON

Jane Turner at World Pharma Pricing and Market Access 2018

Maarten Van Baelen, Market Access Director, Medicines for Europe

Ellen Vanhaeren, Advisor, Minister for Social Security and Public Health, Belgian Federal Government

Ellen Vanhaeren at World Pharma Pricing and Market Access 2018

Peter Vanovertveld, Senior Vice President, Head of Global Pricing & Market Access, Vifor Pharma

Peter Vanovertveld at World Pharma Pricing and Market Access 2018

Bart Vermeulen, Deputy Director Healthcare at Office of the Minister of Social Affairs and Public Health, Belgian Federal Government

Bart Vermeulen at World Pharma Pricing and Market Access 2018

Reg Waldeck, Market Access Strategy Leader, Bayer Corp

Reg Waldeck at World Pharma Pricing and Market Access 2018

Darren Walsh, Senior Director - Market Access & Govt. Affairs – EU, Orchard Therapeutics

Darren Walsh at World Pharma Pricing and Market Access 2018

David Watson, Director Pricing and Reimbursement, Association of the British Pharmaceutical Industry

Clive Whitcher, Vice President of Global Pricing and Patient Access, Sobi

Clive Whitcher at World Pharma Pricing and Market Access 2018

Entela Xoxi, Research Fellow, Universita Cattolica Del Sacro Cuore

Entela Xoxi at World Pharma Pricing and Market Access 2018

Fabrizio Zucca, Director Patient Access DACH, Sobi

Fabrizio Zucca at World Pharma Pricing and Market Access 2018

To speak at the event call Chris Shanks   on
+44 (0)20 7092 1151  or email  chris.shanks@terrapinn.com

 

DOWNLOAD THE PROSPECTUS